Quality of Earnings Analysis and Reports for Healthcare Organizations
Planning an acquisition, sale, or investment, and need insights into the financial health of a healthcare organization? Our Quality of Earnings (QofE) reports evaluate the quality and sustainability of a company’s earnings to mitigate potential risks and support informed decisions. Before making a deal, let HVG peel back the layers.
Quality of Earnings Analysis for Healthcare Businesses
How HVG Conducts QofE Reporting
In our quality of earnings analysis, we model and validate net revenue using proven methodologies that reinforce confidence in the historical results influencing purchase price.
This involves:

Comprehensive Evaluation
Our team of experienced analysts conducts a thorough examination of the financial statements, identifying any irregularities or areas of concern.

Risk Assessment
By assessing the quality of the earnings, we help you identify potential risks and develop strategies to mitigate them, safeguarding the financial health of your target acquisition.

Identification of Key Drivers
We pinpoint the drivers behind the earnings performance, shedding light on both strengths and weaknesses within the operations.

Strategic Recommendations
Armed with our findings, we provide actionable recommendations tailored to your unique circumstances, empowering you to make strategic acquisitions with confidence.
Benefits of a Quality of Earnings Report
A QofE report represents your fair share of financial due diligence before a business transaction. It allows you to:
- Validate EBITDA adjustments: Identify and support non-recurring and out-of-period add-backs to present normalized earnings and clarify enterprise value.
- Resolve accounting issues: Uncover gaps, inconsistencies, or non-GAAP practices that could affect valuation or deal timing.
- Improve transaction efficiency: Anticipate buyer questions and streamline diligence to reduce pressure on internal teams post LOI.
- Control the financial narrative: Present a defensible, well-supported view of adjusted EBITDA to prevent misunderstandings and protect value.
- Set a realistic working capital target: Normalize working capital needs to prevent closing surprises and reduce purchase price disputes.
- Boost credibility and support: Strengthen financial reporting, especially when audited statements are limited, and provide transaction-focused insights using up-to-date, relevant financial periods.
Why Work With HVG?
Bringing 50+ years of combined experience, HVG delivers the insight and leverage of a large firm with the personal attention of a boutique in our QofE analyses. We help clients navigate financial diligence before sale/purchase, valuation, tax considerations, negotiations, and overall deal strategy to maximize opportunities in the market.
Our services span traditional provider organizations as well as healthcare-adjacent companies like DME, staffing agencies, home health, and behavioral health. Clients get:
- Quality of Earnings (QofE) and Quality of Revenue analysis.
- Pre-LOI financial diligence and risk assessment.
- Cash-to-accrual conversions.
- Identification and evaluation of management-provided adjustments.
Reach out to learn how HVG can support your decision-making and help you achieve your objectives.
HVG’s Other Services
Planning a partner buy-in/buyout, sale/acquisition, merger, or raising debt/equity for a big move? HVG provides healthcare business valuation services to establish Fair Market Value (FMV), manage risks, ensure compliance, and support smarter deals.
HVG provides specialized expertise in determining the FMV of healthcare-related intangible assets like Certificates of Need (CONs), operational licenses, non-compete agreements, trademarks, trade names, and professional goodwill.
We provide capital equipment valuations as part of our healthcare valuation services. Each machinery and equipment appraisal complies with Uniform Standards of Professional Appraisal Practice (USPAP) and utilizes the appropriate premise of value.
HVG can determine the fair market value compensation for medical directorships, on-call arrangements, physical recruitment, speaker programs, and a wide range of other physician-hospital arrangements and partnerships.
The HVG team has 15+ years of experience quantifying commercial/economic damages, enabling us to provide expert litigation and witness support services for dispute and litigation matters on the state and federal levels.
Testimonials
I just wanted to say thank you for the exceptional diligence and speed in helping us with our critical FMV efforts. I honestly didn’t think it would be possible to meet our deadline and we were already prepared to postpone the meeting, but incredibly you came through, and we were able to move forward to the pleasant surprise of all parties involved…
Eddie Kalmykov, Ph.D.
AltaThera Pharmaceuticals
I want to share my sincere appreciation to Chris David and the HVG team for their work in helping us enhance our FMV process. Chris is extremely knowledgeable on the topic and provided great input throughout the process. The deliverables we received were thorough and well-constructed and have set us well for immediate implementation.
VP of Compliance
Life Sciences Company
Great job and money well spent in hiring you and your team!! We really appreciate the effort you put into your research. It’s apparent that the judge found your method/approach more realistic than Plaintiff’s. Based on the evidence presented, the Court finds that it is more reasonable to follow the general approach of Mr. David.
Owner
DME Company
Blog
Investing in Ketamine Clinics? Key Legal and Practical Considerations for Investors
Ketamine clinics offer investors accessible entry into psychedelic-assisted psychotherapy, as ketamine is already an approved, prescribable drug. Lisa Gora of
DOJ Declines to Create Employment Safe Harbor Under EKRA; Providers Should Take Heed
On Sept. 25, 2026, the U.S. Department of Justice denied a petition from the American Clinical Laboratory Association (ACLA) seeking
Buy-Side and Sell-Side Financial Due Diligence and Advisory Support
Strengthen your healthcare transactions with informed, data-driven analysis into an organization’s financial performance. Our team of experienced M&A professionals delivers detailed QofE reports that help you uncover the details you need to make defensible decisions that further your business objectives.
FAQs
What’s the difference between a QofE and audited financials?
Audited financials assess historical accuracy and compliance. A QofE analyzes recent performance, adjusts for non-recurring activity, and focuses on what buyers care about most: sustainable earnings and risk.
What is included in a QofE analysis beyond EBITDA adjustments?
In addition to normalizing EBITDA, we evaluate working capital trends, revenue and profitability trends, debt-like items, customer and vendor concentrations, accounting policy, consistency, and the quality of internal financial controls.
How is your approach different from other providers?
We have ex-Big 4 Partners with experience in both buy-side and sell-side QofE that focus on providing actionable insights. Our team combines deep technical knowledge with industry experience to uncover what others may miss.
How long does a typical QofE engagement take?
Most projects take 3-6 weeks, depending on the complexity of the business and the responsiveness of your internal team. We offer flexible timelines when transactions require a faster turnaround.
What do you need from us to get started?
We’ll need recent financial statements, trial balances, bank reconciliations, management reports, and key contracts. We’ll guide your team through a clear data request list and coordinate timelines to minimize disruption.